AVXL vs OXY · $247.4M cap vs rev $13.29B
Anavex Life Sciences Corp (AVXL) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
Anavex Life Sciences Corp (AVXL) is a biotechnology company listed on NASDAQ.
OXY (OXY) common stock.
AVXL does not have a complete income-statement cache yet.
Latest reported OXY revenue for 2026-06-30 was $13.29B. Net income was $6.36B. OXY currently screens at market cap $0.
AVXL currently screens at market cap $247.4M. OXY currently screens at market cap $0.
Not investment advice. Open the AVXL and OXY stock pages for the full models.
Not investment advice.